160 related articles for article (PubMed ID: 23248401)
1. Comparison of reservoir effect of topical corticosteroids in an experimental animal model by histamine-induced wheal suppression test.
Abidi A; Ahmad F; Singh SK; Kumar A
Indian J Pharmacol; 2012; 44(6):722-5. PubMed ID: 23248401
[TBL] [Abstract][Full Text] [Related]
2. Study of reservoir effect of clobetasol propionate cream in an experimental animal model using histamine-induced wheal suppression test.
Abidi A; Ahmad F; Singh SK; Kumar A
Indian J Dermatol; 2010 Oct; 55(4):329-33. PubMed ID: 21430883
[TBL] [Abstract][Full Text] [Related]
3. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
Singh SK; Nasir F
Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
[TBL] [Abstract][Full Text] [Related]
4. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
Prakash A; Benfield P
Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
Korting HC; Maslen K; Gross G; Willers C
J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Bjerring P
Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
[TBL] [Abstract][Full Text] [Related]
7. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
Singh S; Gupta A; Pandey SS; Singh G
Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
[TBL] [Abstract][Full Text] [Related]
8. Once-a-day topical corticosteroids.
Drug Ther Bull; 1995 Mar; 33(3):21-2. PubMed ID: 7587987
[No Abstract] [Full Text] [Related]
9. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
[TBL] [Abstract][Full Text] [Related]
10. Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris.
Queille-Roussel C; Nielsen J; Lacour JP
J Dermatolog Treat; 2019 Sep; 30(6):529-533. PubMed ID: 30582717
[No Abstract] [Full Text] [Related]
11. Fitting Pharmacodynamic Data to the
Tapfumaneyi P; Rath S; Bon C; Kanfer I
Mol Pharm; 2022 Aug; 19(8):2900-2906. PubMed ID: 35763717
[TBL] [Abstract][Full Text] [Related]
12. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses.
Viglioglia P; Jones ML; Peets EA
J Int Med Res; 1990; 18(6):460-7. PubMed ID: 2292327
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone.
Mose KF; Andersen F; Røpke MA; Skov L; Friedmann PS; Andersen KE
Br J Clin Pharmacol; 2018 Aug; 84(8):1719-1728. PubMed ID: 29607554
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children.
Pei AY; Chan HH; Ho KM
Pediatr Dermatol; 2001; 18(4):343-8. PubMed ID: 11576413
[TBL] [Abstract][Full Text] [Related]
15. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
Green L; Sadoff W
J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
Vernon HJ; Lane AT; Weston W
J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
[TBL] [Abstract][Full Text] [Related]
17. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.
Affrime MB; Banfield C; Nolop K
Eur Respir J; 2001 Jul; 18(1):246. PubMed ID: 11510799
[No Abstract] [Full Text] [Related]
18. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
Crim C; Pierre LN; Daley-Yates PT
Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic efficacy of mometasone furoate cream 0.1% applied once daily vs clobetasol propionate cream 0.05% applied twice daily in chronic eczema.
Goh CL; Lim JT; Leow YH; Ang CB; Kohar YM
Singapore Med J; 1999 May; 40(5):341-4. PubMed ID: 10489492
[TBL] [Abstract][Full Text] [Related]
20. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
Gregurek-Novak T
J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):81-2. PubMed ID: 11451336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
